AZD8330, MEK inhibitor

Alternative names

CFC syndrome, CFC4, Cardiofaciocutaneous syndrome, Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 2, Dual specificity mitogen-activated protein kinase kinase 5, E2AK1_HUMAN, EC 2.7.11.1, EC 2.7.12.2, EIF2AK1, ERK activator kinase 1, ERK activator kinase 2, Eukaryotic translation initiation factor 2-alpha kinase 1, FLJ26075, HCR, HRI, Heme regulated initiation factor 2 alpha kinase, Heme regulated repressor, Heme sensitive initiation factor 2a kinase, Heme-controlled repressor, Heme-regulated eukaryotic initiation factor eIF-2-alpha kinase, Heme-regulated inhibitor, Hemin-sensitive initiation factor 2-alpha kinase, HsT17454, KIAA1369, MAP kinase kinase 1, MAP kinase kinase 2, MAP kinase kinase 5, MAP kinase kinase MEK5b, MAP kinase/Erk kinase 1, MAP2K1, MAP2K2, MAP2K5, MAPK / ERK kinase 2, MAPK/ERK kinase 1, MAPK/ERK kinase 5, MAPKK 1, MAPKK 2, MAPKK 5, MEK 1, MEK 2, MEKK 1, MKK 1, MKK 2, MKK5, MP2K1_HUMAN, MP2K2_HUMAN, MP2K5_HUMAN, Microtubule associated protein kinase kinase 2, Mitogen Activated Protein Kinase Kinase 1, Mitogen activated protein kinase kinase 2, Mitogen activated protein kinase kinase 2 p45, OTTHUMP00000165826, OTTHUMP00000165827, PRKMK 1, PRKMK 2, PRKMK5, PRO1362, Protein kinase mitogen activated kinase 1 (MAP kinase kinase 1), Protein kinase, mitogen-activated, kinase 5, SAPKK5, SKK5, mitogen-activated protein kinase kinase 5, protein kinase mitogen-activated kinase 1